- FDA approves new drug that may help stop and even reverse a rare, fatal condition that doctors call a ‘ticking time bomb’ CNN
- FDA approves Merck’s drug for rare, deadly lung condition CNBC
- FDA Approves Potential ‘Game Changer’ for Pulmonary Arterial Hypertension BioSpace
- Merck Stock: Is The Cardiovascular Renaissance Here With Sotatercept Approval? Investor’s Business Daily
- Merck’s $11.5 Billion Bet on Its Next Big Drug Finally Arrives The Wall Street Journal
Source: Google Finance – Market News